MOVE vs MNMD vs LWAY vs HIMS vs JJSF

For growth investors, Hims & Hers Health, Inc.

(HIMS) is the stronger pick with 59. 0% revenue growth year-over-year, versus 0. 5% for J&J Snack Foods Corp. (JJSF). J&J Snack Foods Corp. (JJSF) offers the better valuation at 22. 5x trailing P/E (17. 5x forward), making it the more compelling value choice. Analysts rate Movano Inc. (MOVE) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, J&J Snack Foods Corp.

(JJSF) is the cheapest at 22. 5x versus Hims & Hers Health, Inc. at 50. 3x. On forward P/E, J&J Snack Foods Corp. is actually cheaper at 17. 5x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: J&J Snack Foods Corp. wins at 0. 62x versus Lifeway Foods, Inc. 's 0. 62x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

Over the past 5 years, Lifeway Foods, Inc.

(LWAY) delivered a total return of +427. 0%, compared to -98. 2% for Movano Inc. (MOVE). Over 10 years, the gap is even starker: MNMD returned +512. 1% versus MOVE's -98. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), J&J Snack Foods Corp.

(JJSF) is the lower-risk stock at 0. 15β versus Hims & Hers Health, Inc. 's 2. 40β — meaning HIMS is approximately 1472% more volatile than JJSF relative to the S&P 500. On balance sheet safety, Lifeway Foods, Inc. (LWAY) carries a lower debt/equity ratio of 0% versus 2% for Hims & Hers Health, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Hims & Hers Health, Inc.

(HIMS) is pulling ahead at 59. 0% versus 0. 5% for J&J Snack Foods Corp. (JJSF). On earnings-per-share growth, the picture is similar: Lifeway Foods, Inc. grew EPS 50. 8% year-over-year, compared to -1273. 3% for Mind Medicine (MindMed) Inc.. Over a 3-year CAGR, HIMS leads at 64. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Lifeway Foods, Inc.

(LWAY) is the more profitable company, earning 6. 5% net margin versus -23. 4% for Movano Inc. — meaning it keeps 6. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LWAY leads at 7. 6% versus -23. 9% for MOVE. At the gross margin level — before operating expenses — HIMS leads at 59. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, J&J Snack Foods Corp. (JJSF) is the more undervalued stock at a PEG of 0. 62x versus Lifeway Foods, Inc. 's 0. 62x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, J&J Snack Foods Corp. (JJSF) trades at 17. 5x forward P/E versus 51. 5x for Hims & Hers Health, Inc. — 34. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for LWAY: 36. 5% to $35. 00.

In this comparison, JJSF (4.

1% yield) pays a dividend. MOVE, MNMD, LWAY, HIMS do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, J&J Snack Foods Corp.

(JJSF) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 15), 4. 1% yield). Movano Inc. (MOVE) carries a higher beta of 1. 98 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (JJSF: -5. 2%, MOVE: -98. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (MOVE (Healthcare) and MNMD (Healthcare) and LWAY (Consumer Defensive) and HIMS (Healthcare) and JJSF (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: MOVE is a small-cap quality compounder stock; MNMD is a small-cap quality compounder stock; LWAY is a small-cap quality compounder stock; HIMS is a small-cap high-growth stock; JJSF is a small-cap income-oriented stock. JJSF pays a dividend while MOVE, MNMD, LWAY, HIMS do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.